Becton Dickinson Other Operating Income or Expenses 2010-2024 | BDX

Becton Dickinson annual/quarterly other operating income or expenses history and growth rate from 2010 to 2024. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
  • Becton Dickinson other operating income or expenses for the quarter ending September 30, 2024 were $-0.137B, a 155.24% decline year-over-year.
  • Becton Dickinson other operating income or expenses for the twelve months ending September 30, 2024 were $-0.298B, a 241.9% decline year-over-year.
  • Becton Dickinson annual other operating income or expenses for 2024 were $-0.222B, a 205.71% decline from 2023.
  • Becton Dickinson annual other operating income or expenses for 2023 were $0.21B, a 667.57% decline from 2022.
  • Becton Dickinson annual other operating income or expenses for 2022 were $-0.037B, a 81.77% decline from 2021.
Becton Dickinson Annual Other Operating Income or Expenses
(Millions of US $)
2024 $-222
2023 $210
2022 $-37
2021 $-203
2020 $-363
2019 $-654
2018 $
2017 $-410
2016 $
2015 $
2014 $
2013 $
2012 $
2011 $
2010 $
2009 $
Becton Dickinson Quarterly Other Operating Income or Expenses
(Millions of US $)
2024-09-30 $-137
2024-06-30 $-98
2024-03-31 $23
2023-12-31 $-86
2023-09-30 $248
2023-06-30 $13
2023-03-31 $-4
2022-12-31 $-47
2022-09-30 $-30
2022-06-30 $-11
2022-03-31
2021-12-31 $4
2021-09-30 $5
2021-06-30 $88
2021-03-31 $-296
2020-12-31
2020-09-30 $-378
2020-06-30 $15
2020-03-31
2019-12-31
2019-09-30 $-593
2019-06-30
2019-03-31 $-396
2018-12-31 $335
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30 $-5
2017-06-30 $-741
2017-03-31
2016-12-31 $336
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $64.352B $20.178B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.151B 21.33
Cardinal Health (CAH) United States $28.637B 15.53
West Pharmaceutical Services (WST) United States $22.024B 44.99
Labcorp (LH) United States $19.758B 16.38
Cooper (COO) United States $19.726B 28.08
Align Technology (ALGN) United States $16.616B 31.80
Henry Schein (HSIC) United States $9.331B 17.78
Merit Medical Systems (MMSI) United States $6.102B 31.16
DENTSPLY SIRONA (XRAY) United States $3.753B 10.20
CONMED (CNMD) United States $2.216B 18.49
Patterson (PDCO) United States $1.799B 9.49
STAAR Surgical (STAA) United States $1.288B 47.53
Lifevantage (LFVN) United States $0.170B 22.60
Pro-Dex (PDEX) United States $0.147B 29.36